Neuroone Medical Technologies (NMTC) Depreciation and Depletion (2019 - 2026)
Neuroone Medical Technologies (NMTC) posted Depreciation and Depletion of $54450.0 for Q1 2026, down 9.17% on a QoQ basis from $59945.0 in Q4 2025, and down 9.33% year-over-year from $60055.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Depreciation and Depletion (2019 - 2026) Analysis & Trends
Neuroone Medical Technologies' Depreciation and Depletion history runs 8 years deep, the most recent figure standing at $54450.0 for Q1 2026.
- Quarterly Depreciation and Depletion fell 9.33% year-over-year to $54450.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $234155.0 (down 0.65% YoY) and the FY2025 annual result came in at $239363.0, up 6.63% from the prior year.
- Depreciation and Depletion was $54450.0 for Q1 2026 at Neuroone Medical Technologies, down from $59945.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $61015.0 in Q2 2025 and bottomed at $22952.0 in Q1 2022.
- A 5-year average of $48935.8 and a median of $55321.0 in 2024 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2023 — Depreciation and Depletion soared 104.47% — and 2026, when it slipped 9.33%.
- Neuroone Medical Technologies' Depreciation and Depletion stood at $30310.0 in 2022, then surged by 75.12% to $53078.0 in 2023, then gained by 12.19% to $59548.0 in 2024, then climbed by 0.67% to $59945.0 in 2025, then slipped by 9.17% to $54450.0 in 2026.
- Business Quant data shows NMTC's Depreciation and Depletion at $54450.0 in Q1 2026, $59945.0 in Q4 2025, and $58745.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | 54,450.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54,450.00 |
| Mar 31, 2026 | 54,450.00 |
| Dec 31, 2025 | 59,945.00 |
| Dec 31, 2025 | 59,945.00 |
| Sep 30, 2025 | 58,745.00 |
| Sep 30, 2025 | 58,745.00 |
| Jun 30, 2025 | 61,015.00 |
| Jun 30, 2025 | 61,015.00 |
| Mar 31, 2025 | 60,055.00 |
| Mar 31, 2025 | 60,055.00 |
| Dec 31, 2024 | 59,548.00 |
| Dec 31, 2024 | 59,548.00 |
| Sep 30, 2024 | 58,548.00 |
| Sep 30, 2024 | 58,548.00 |
| Jun 30, 2024 | 57,529.00 |
| Jun 30, 2024 | 57,529.00 |
| Mar 31, 2024 | 55,321.00 |
| Mar 31, 2024 | 55,321.00 |
| Dec 31, 2023 | 53,078.00 |
| Dec 31, 2023 | 53,078.00 |